APPROPRIATENESS OF USING PATIENT-DERIVED XENOGRAFT MODELS FOR PHARMACOLOGIC EVALUATION OF NOVEL THERAPIES FOR ESOPHAGEAL/GASTRO-ESOPHAGEAL JUNCTION CANCERS.

Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.

The high morbidity and mortality of patients with esophageal (E) and gastro-esophageal junction (GEJ) cancers, warrants new pre-clinical models for drug testing.The utility of primary tumor xenografts (PTXGs) as pre-clinical models was assessed.Clinicopathological, immunohistochemical markers (p53, p16, Ki-67, Her-2/neu and Home Coffee Machines EGF

read more


Letter in Reply: Epidemiology of COVID-19 Infection in Oman

We read with keen interest the remarks made by Al-Mendalawi,1 and thank 3 Piece Twin Bookcase Bed him for his interest in our manuscript.In our study, we described the epidemiological aspects of the first 1304 laboratory-confirmed cases (incidence) in Oman.Oman has a strong communicable disease surveillance system across all governorates and region

read more